JPWO2023140357A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2023140357A5 JPWO2023140357A5 JP2023554283A JP2023554283A JPWO2023140357A5 JP WO2023140357 A5 JPWO2023140357 A5 JP WO2023140357A5 JP 2023554283 A JP2023554283 A JP 2023554283A JP 2023554283 A JP2023554283 A JP 2023554283A JP WO2023140357 A5 JPWO2023140357 A5 JP WO2023140357A5
- Authority
- JP
- Japan
- Prior art keywords
- aqueous liquid
- liquid preparation
- arbekacin
- salt
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007788 liquid Substances 0.000 claims 14
- MKKYBZZTJQGVCD-XTCKQBCOSA-N arbekacin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O1)O)NC(=O)[C@@H](O)CCN)[C@H]1O[C@H](CN)CC[C@H]1N MKKYBZZTJQGVCD-XTCKQBCOSA-N 0.000 claims 11
- 229960005397 arbekacin Drugs 0.000 claims 11
- 150000003839 salts Chemical class 0.000 claims 8
- 229920003169 water-soluble polymer Polymers 0.000 claims 8
- 239000007864 aqueous solution Substances 0.000 claims 4
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims 4
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims 4
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims 4
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims 4
- 208000001860 Eye Infections Diseases 0.000 claims 2
- 230000001580 bacterial effect Effects 0.000 claims 2
- 208000011323 eye infectious disease Diseases 0.000 claims 2
- 208000003556 Dry Eye Syndromes Diseases 0.000 claims 1
- 206010013774 Dry eye Diseases 0.000 claims 1
- 239000003889 eye drop Substances 0.000 claims 1
- 230000005012 migration Effects 0.000 claims 1
- 238000013508 migration Methods 0.000 claims 1
- 230000000087 stabilizing effect Effects 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024065941A JP2024096898A (ja) | 2022-01-21 | 2024-04-16 | 水性液剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022007774 | 2022-01-21 | ||
| JP2022007774 | 2022-01-21 | ||
| PCT/JP2023/001725 WO2023140357A1 (ja) | 2022-01-21 | 2023-01-20 | 水性液剤 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024065941A Division JP2024096898A (ja) | 2022-01-21 | 2024-04-16 | 水性液剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2023140357A1 JPWO2023140357A1 (https=) | 2023-07-27 |
| JPWO2023140357A5 true JPWO2023140357A5 (https=) | 2023-12-20 |
| JP7479744B2 JP7479744B2 (ja) | 2024-05-09 |
Family
ID=87348335
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023554283A Active JP7479744B2 (ja) | 2022-01-21 | 2023-01-20 | 水性液剤 |
| JP2024065941A Pending JP2024096898A (ja) | 2022-01-21 | 2024-04-16 | 水性液剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024065941A Pending JP2024096898A (ja) | 2022-01-21 | 2024-04-16 | 水性液剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US12296015B2 (https=) |
| EP (1) | EP4467144A4 (https=) |
| JP (2) | JP7479744B2 (https=) |
| KR (1) | KR20240134913A (https=) |
| CN (1) | CN118613267A (https=) |
| CA (1) | CA3244189A1 (https=) |
| MX (1) | MX2024009025A (https=) |
| WO (1) | WO2023140357A1 (https=) |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5651499A (en) | 1979-10-01 | 1981-05-09 | Meiji Seika Kaisha Ltd | Aminoglycoside derivative and its preparation |
| JPS58134099A (ja) | 1982-02-05 | 1983-08-10 | Meiji Seika Kaisha Ltd | アミノ配糖体抗生物質の精製法 |
| JP2002097129A (ja) * | 2000-07-21 | 2002-04-02 | Rohto Pharmaceut Co Ltd | 点眼剤 |
| EP1683526B1 (en) * | 2003-11-14 | 2012-04-11 | Senju Pharmaceutical Co., Ltd. | Aqueous solution preparation containing aminoglycoside antibiotic and bromfenac |
| JP4736540B2 (ja) * | 2004-05-27 | 2011-07-27 | 参天製薬株式会社 | 眼科用粘稠化剤 |
| ES2510667T3 (es) | 2004-05-27 | 2014-10-21 | Santen Pharmaceutical Co., Ltd | Colirio |
| US8748402B2 (en) * | 2004-06-07 | 2014-06-10 | Bausch & Lomb Pharma Holdings Corp. | Ophthalmic formulations and uses thereof |
| CN105944105A (zh) | 2008-06-12 | 2016-09-21 | 前瞻生物治疗公司 | 一种眼科组合物中的防腐剂替代物聚维酮碘 |
| WO2010141831A1 (en) * | 2009-06-05 | 2010-12-09 | Aciex Therapeutics, Inc. | Ophthalmic formulations, methods of manufacture, and methods of using same |
| US8211450B2 (en) * | 2010-05-05 | 2012-07-03 | Senju Usa, Inc. | Ophthalmic composition |
| ES2532667T3 (es) | 2011-09-12 | 2015-03-30 | Meiji Seika Pharma Co., Ltd. | Composiciones acuosas que contienen arbekacina |
| JP2018522070A (ja) | 2015-07-27 | 2018-08-09 | キャタコア・インコーポレイテッドＣａｔａｃｏｒｅ， Ｉｎｃ． | 白内障の処置用組成物 |
| CN106474149A (zh) * | 2016-12-23 | 2017-03-08 | 常州润诺生物科技有限公司 | 一种复方氨基糖苷类抗生素的口服制剂及其制备方法与应用 |
| CN106420811A (zh) * | 2016-12-23 | 2017-02-22 | 常州润诺生物科技有限公司 | 一种氨基糖苷类抗生素的口服制剂及其制备方法与应用 |
-
2023
- 2023-01-20 WO PCT/JP2023/001725 patent/WO2023140357A1/ja not_active Ceased
- 2023-01-20 CN CN202380018185.6A patent/CN118613267A/zh active Pending
- 2023-01-20 JP JP2023554283A patent/JP7479744B2/ja active Active
- 2023-01-20 KR KR1020247024814A patent/KR20240134913A/ko active Pending
- 2023-01-20 CA CA3244189A patent/CA3244189A1/en active Pending
- 2023-01-20 EP EP23743349.5A patent/EP4467144A4/en active Pending
- 2023-01-20 MX MX2024009025A patent/MX2024009025A/es unknown
-
2024
- 2024-04-16 JP JP2024065941A patent/JP2024096898A/ja active Pending
- 2024-05-09 US US18/659,629 patent/US12296015B2/en active Active
-
2025
- 2025-04-08 US US19/173,248 patent/US20250235541A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020138980A5 (https=) | ||
| CN116171275A8 (zh) | Resmetirom的晶型及其制备方法和用途 | |
| JP2022003099A5 (https=) | ||
| JP2019081783A5 (https=) | ||
| JP2022511335A5 (https=) | ||
| JP2011513492A5 (https=) | ||
| NO20051688L (no) | Farmasoytiske blandinger som har en modifisert baerer | |
| JP6820430B2 (ja) | コットンキャンディ剤形の機能性物質含有化粧料組成物 | |
| MY209059A (en) | Aqueous ophthalmic composition comprising diquafosol or salt thereof and polyvinylpyrrolidone | |
| JP2009544665A5 (https=) | ||
| JP2012246304A (ja) | α−２−アドレナリンアゴニスト成分を含有する組成物 | |
| JP2019142974A5 (https=) | ||
| JPWO2023140357A5 (https=) | ||
| JP2019526631A5 (https=) | ||
| JP2022082779A5 (https=) | ||
| AR110250A1 (es) | Formulación tópica que comprende n-[5-(aminosulfonil)-4-metil-1,3-tiazol-2-il]-n-metil-2-[4-(2-piridinil)-fenil]-acetamida | |
| Polet et al. | Malaria: extracellular amino acid requirements for in vitro growth of erythrocytic forms of Plasmodium knowlesi | |
| JP2008540528A5 (https=) | ||
| JP6275725B2 (ja) | 胃食道疾患を治療するための方法および組成物 | |
| JP2024096898A5 (https=) | ||
| JP2019502719A5 (https=) | ||
| JP2017516838A5 (https=) | ||
| JP2021502337A5 (https=) | ||
| JP4956981B2 (ja) | オキシメタゾリン含有水性組成物 | |
| CN115974851A8 (zh) | 2-氧代-3-氮杂双环[3.1.0]己烷衍生物 |